Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy

NACompletedINTERVENTIONAL

Enrollment

1,058

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions

Vaginal InfectionPregnancy ComplicationsNeonatal SepsisGBS

Interventions

DIETARY_SUPPLEMENT

Astarte® (HSO Health Care GmbH, Vienna, Austria)

oral intake of Astarte® (HSO Health Care GmbH, Vienna, Austria) as described

OTHER

Placebo

Identical-looking oral potato-maltodextrin-based placebo

Trial Locations (1)

Medical University of Vienna, Vienna General Hospital, Department of Obstetrics and Gynecology, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT03008421 - Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy | Biotech Hunter | Biotech Hunter